Search Within

Jaclyn Frances Hechtman

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (65)
  2. Journal Article (63)
  3. Review (2)
  4. Book Section (1)
  5. Guidelines (1)
  6. Research Letter (1)
Groups
  1. GSK Faculty (133)
  2. Human Oncology and Pathogenesis Program (133)
  3. Department of Pathology and Laboratory Medicine (125)
  4. Department of Medicine (112)
  5. Solid Tumor Oncology Division (112)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (90)

More Groups

People
  1. Marc Ladanyi (69)
  2. Michael Berger (66)
  3. David Solit (52)
  4. Ahmet Zehir (50)
  5. Nikolaus Schultz (47)
  6. Jinru Shia (46)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (1)
  5. 2021 (10)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Modern Pathology (16)
  3. Clinical Cancer Research (12)
  4. Laboratory Investigation (11)
  5. Journal of Molecular Diagnostics (10)
  6. Annals of Oncology (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. American Association for Cancer Research (25)
  3. Nature Publishing Group (17)
  4. Nature Research (16)
  5. Elsevier Science, Inc. (11)
  6. Oxford University Press (8)

More Publishers

Results (133)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma
    Meeting Abstract

    Chiang, S.; Cotzia, P.; Hyman, D.; Drilon, A.; Hechtman, J.; Jungbluth, A.; Murali, R.; Soslow, R.; Oliva, E.; Benayed, R.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children
    Journal Article

    Drilon, A.; Laetsch, T. W.; Kummar, S.; DuBois, S. G.; Lassen, U. N.; Demetri, G. D.; Nathenson, M.; Doebele, R. C.; Farago, A. F.; Pappo, A. S.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Genetic predictors of response to systemic therapy in esophagogastric cancer
    Journal Article

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Chatila, W. K.; Hechtman, J. F.; Ku, G. Y.; Riches, J. C.; Tuvy, Y.; Kundra, R.; Bouvier, N.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Clinical sequencing defines the genomic landscape of metastatic colorectal cancer
    Journal Article

    Yaeger, R.; Chatila, W. K.; Lipsyc, M. D.; Hechtman, J. F.; Cercek, A.; Sanchez-Vega, F.; Jayakumaran, G.; Middha, S.; Zehir, A.; Donoghue, M. T. A.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Successful targeted therapy of refractory pediatric ETV6-NTRK3 fusion-positive secretory breast carcinoma
    Journal Article

    Shukla, N.; Roberts, S. S.; Baki, M. O.; Mushtaq, Q.; Goss, P. E.; Park, B. H.; Gundem, G.; Tian, K.; Geiger, H.; Redfield, K.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Mutational profiling of resected intrahepatic cholangiocarcinoma
    Meeting Abstract

    Pak, L. M.; Goldman, D.; Gonen, M.; Allen, P. J.; Balachandran, V. P.; D'Angelica, M. I.; DeMatteo, R. P.; Kingham, T. P.; Simpson, A.; Hechtman, J. F.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Correlation of benefit from immune checkpoint inhibitors with next gen sequencing (NGS) profiles in esophagogastric cancer (EGC) patients
    Meeting Abstract

    Ku, G. Y.; Sanchez-Vega, F.; Chatila, W.; Margolis, M.; Fein, C.; Ilson, D. H.; Hechtman, J. F.; Tuvy, Y.; Bouvier, N.; Kundra, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Molecular pathology of pancreatic cancer and premalignant tumors
    Book Section

    Hechtman, J. F.; Iacobuzio-Donahue, C.
    In Jarnagin, W. R.; Allen, P. J.; Chapman, W. C.; D'Angelica, M. I.; DeMatteo, R. P.; Do, R. K. G.; Vauthey, J. N.; Blumgart, L. H. (Eds.) Blumgart's Surgery of the Liver, Biliary Tract and Pancreas. 6th ed (2017)

    Fulltext@MSK | Save
  • Mechanisms of acquired resistance to BRAF V600E inhibition in colon cancers converge on RAF dimerization and are sensitive to its inhibition
    Journal Article

    Yaeger, R.; Yao, Z.; Hyman, D. M.; Hechtman, J. F.; Vakiani, E.; Zhao, H.; Su, W.; Wang, L.; Joelson, A.; Cercek, A.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Real-time genomic profiling of pancreatic ductal adenocarcinoma: Potential actionability and correlation with clinical phenotype
    Journal Article

    Lowery, M. A.; Jordan, E. J.; Basturk, O.; Ptashkin, R. N.; Zehir, A.; Berger, M. F.; Leach, T.; Herbst, B.; Askan, G.; Maynard, H.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save